PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
Amand F. Schmidt(University of Cambridge), Andrzej Pająk(Jagiellonian University), Jackie F. Price(University of Edinburgh), Kristina Norman(University of Potsdam), Karin Willeit(Innsbruck Medical University), Stela McLachlan(University of Edinburgh), Catherine Welch(University College London), Elisabeth Steinhagen‐Thiessen(Charité - Universitätsmedizin Berlin), Richard Morris(University of Nottingham), Zammy Fairhurst-Hunter(Centre for Human Genetics), Elina Hyppönen(South Australian Health and Medical Research Institute), Jian’an Luan(University of Cambridge), Bernardo Lessa Horta(Universidade Federal de Pelotas), Mika Kivimäki(University of Helsinki), Juri Demuth, Adelaida Sánchez-Gálvez(University College London), Dan Mason(Bradford Teaching Hospitals NHS Foundation Trust), Sofia Malyutina(Research Institute of Therapy and Preventive Medicine), Carlotta Sacerdote(Cancer Prevention Institute of California), N. Charlotte Onland‐Moret(St. Elizabeth's Hospital), Johann Willeit(Innsbruck Medical University), Stefan Kiechl(Innsbruck Medical University), Pedro Marques‐Vidal(University Hospital of Lausanne), Yoav Ben‐Shlomo(University of Bristol), Yvonne T. van der Schouw(University Medical Center Utrecht), Simonetta Guarrera(Italian institute for Genomic Medicine), Claudia Langenberg(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Donald M. Lyall(University of Glasgow), Daniel I. Swerdlow(Silence Therapeutics (United Kingdom)), Andrew Nicolaides(Imperial College London), Andrie G. Panayiotou(Cyprus University of Technology), Peter H. Whincup(St George's, University of London), Martin Bobák(Masaryk University), Riyaz Patel(University College London), Ilja Demuth(Charité - Universitätsmedizin Berlin), Max Moldovan(University of South Australia), John Wright(Bradford Teaching Hospitals NHS Foundation Trust), Fernando Pires Hartwig(Universidade Federal de Pelotas), Giuseppe Matullo(Italian institute for Genomic Medicine), Stefan Coassin(Innsbruck Medical University), Giovanni Fiorito(Italian institute for Genomic Medicine), Tian Liu(Max Planck Institute for Human Development), Nicholas J. Wareham(University of Cambridge), Christine Power(Great Ormond Street Hospital), Michael V. Holmes(University of Bristol), Erik Van Iperen(Amsterdam UMC Location University of Amsterdam), G. Kees Hovingh(Academic Medical Center), Goya Wanamethee(University College London), Robert A. Scott(The Edgbaston Hospital), Lars Bertram(Universitat Internacional de Catalunya)
Cited by 390
Related Papers
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
|American Journal of Psychiatry|2007|5.3k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k